Matteo Lambertini: Andrea Botticelli a massive italian precision medicine effort
Matteo Lambertini shared on X:
“Just presented at the ESMO24 Presidential Symposium III by the king Andrea Botticelli a massive italian precision medicine effort….fantastic presentation my friend and super important data!!!”
Source: Matteo Lambertini/X
More psots featuring ESMO24 on oncodaily.com
Matteo Lambertini is an adjunct professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital and the University of Genova in Italy. He specializes in managing breast cancer in young women, particularly addressing fertility and pregnancy-related issues post-diagnosis. Lambertini’s notable research includes using GnRH agonists during chemotherapy to preserve ovarian function and studying the safety of pregnancy after breast cancer. He also serves on the scientific boards of ESMO, ESHRE, and AIOM for fertility preservation in cancer patients.
Andrea Botticelli is an Assistant Professor at Sapienza University of Rome and the Coordinator of the Breast Unit at Umberto I University Hospital. His research focuses on precision and personalized medicine, particularly in breast cancer. He is involved in the study of biomarkers, specifically SNPs (single nucleotide polymorphisms), to better understand patient metabolism, aiming to reduce unnecessary toxicity and improve treatment compliance.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023